Form 4 for BBOT BridgeBio Oncology Therapeutics, Inc.
Accepted 2026-05-05 19:05:35 ET · period of report 2026-04-01 · accession 0001193125-26-207041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 19:05 | 2026-04-01 | BBOT | Ben Yong | Chief Med, Dev Off | F - Tax | $9.03 | -1,047 | 45.6K | -2% | -$9,454 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | F | D | 1,047 | $9.03 | 45,623 | D | — | — | (F1) Represents shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |